Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Genmab (GMABc)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1,993.00 -1.00    -0.05%
09:34:25 - Closed. Currency in DKK ( Disclaimer )
Type:  Equity
Market:  Euro Zone
ISIN:  DK0010272202 
  • Volume: 192
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 1,974.00 - 1,993.00
Genmab 1,993.00 -1.00 -0.05%

GMABc Ratios

 
Assess the performance of Genmab (GMAB). This table contains core financial ratios such as Price-to-Earnings (P/E ratio), Return-On-Investment (ROI), Earnings per share (EPS), Dividend yield and others based on Genmab's latest financial reports. Compare the performance metrics of Genmab (GMAB) against the industry averages.
InvestingPro Advanced Ratios
Name Company Industry
   
P/E Ratio TTM 29.75 18.42
Price to Sales TTM 7.86 726.53
Price to Cash Flow MRQ 17.55 11.83
Price to Free Cash Flow TTM 18.46 -18.27
Price to Book MRQ 4.1 4.33
Price to Tangible Book MRQ 3.95 4.64
   
Profitability: TTM vs 5 Year Average Margins
 TTM (%)
 5 Year Avg. (%)
Gross margin TTM 98.63% 75.45
Gross Margin 5YA 99.9% 61.8
Operating margin TTM 32.3% -1,062.09
Operating margin 5YA 43.8% -1,500.59
Pretax margin TTM 34.22% -6,411.64
Pretax margin 5YA 48.89% -11,168.43
Net Profit margin TTM 26.42% -6,418.63
Net Profit margin 5YA 39.1% -15,156.85
   
Revenue/Share TTM 252.2 172.96
Basic EPS ANN 66.64 41.64
Diluted EPS ANN 66.02 41.26
Book Value/Share MRQ 483.91 326.75
Tangible Book Value/Share MRQ 482.3 314.06
Cash/Share MRQ 227.59 146.35
Cash Flow/Share TTM 112.98 71.6
   
Management Effectiveness: TTM vs 5 Year Average Margins
 TTM (%)
 5 Year Avg. (%)
Return on Equity TTM 14.78% 5.06
Return on Equity 5YA 20.79% 12.7
Return on Assets TTM 13.31% 7.58
Return on Assets 5YA 18.81% 10.9
Return on Investment TTM 13.78% 9.09
Return on Investment 5YA 18.33% 10.68
   
EPS(MRQ) vs Qtr. 1 Yr. Ago MRQ 24.45% -1.51
EPS(TTM) vs TTM 1 Yr. Ago TTM -20.08% -12.42
5 Year EPS Growth 5YA 22.63% 14.88
Sales (MRQ) vs Qtr. 1 Yr. Ago MRQ -8.94% 17.51
Sales (TTM) vs TTM 1 Yr. Ago TTM 13.57% 44.2
5 Year Sales Growth 5YA 40.35% 36.54
5 Year Capital Spending Growth 5YA 38.43% 28.9
   
Quick Ratio MRQ 13.32 9.45
Current Ratio MRQ 13.34 9.86
LT Debt to Equity MRQ - 45.25
Total Debt to Equity MRQ 2.44% 45.27
Efficiency    
Asset Turnover TTM 0.5 0.44
Inventory Turnover TTM 7.93 6.43
Revenue/Employee TTM 7.47M 4.78M
Net Income/Employee TTM 1.97M 895.93K
Receivable Turnover TTM 3.61 3.75
   
Dividend Yield ANN - 0.34
Dividend Yield 5 Year Avg. 5YA - 0.15
Dividend Growth Rate ANN 0% 26.13
Payout Ratio TTM - 5.73
TTM = Trailing Twelve Months  5YA = 5-Year Average  MRQ = Most Recent Quarter
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced valuation and financial ratios for in-depth analysis of company financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

GMAB Comments

Write your thoughts about Genmab
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Mark Marriott
Mark Marriott Oct 27, 2021 7:48AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
this stock worths buying for the long term?
The Note
TheNote Jul 26, 2021 11:40AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Target 3620 .. medium/long.Daily chart: https://invst.ly/vjgx1 Weekly chart: https://invst.ly/vjgxu
The Note
TheNote Jul 26, 2021 11:33AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Cup with handle - emminent !!!https://www.proinvestor.com/boards/95471Translate from that site (from danish) into english.
BumHunters Archer
JohnJenga Mar 17, 2021 7:29AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
NBI might roll over. Risky now
BumHunters Archer
JohnJenga Mar 07, 2021 1:15PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
1992 indicative price vs 1901 close dk and 1970 close us
BumHunters Archer
JohnJenga Mar 07, 2021 1:15PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
2200 this week possible, imo
BumHunters Archer
JohnJenga Mar 04, 2021 5:31AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
nice correction - but have more or less only removed dec7jan baboon buys
Martin Lynge
Martin Lynge Mar 04, 2021 5:31AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
You mean since June last year.. .. Giant sell out...
Martin Lynge
Martin Lynge Jun 27, 2019 2:52PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
US 1st line approval this evening... 1200+ tomorrow?
Michael Almskov
Michael Almskov Jun 27, 2019 2:10PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://oasm.finanstilsynet.dk/dk/vismeddelelse.aspx?aid=f7f1738b-beb1-47b2-a9dc-ab402ccd42e9
Michael Almskov
Michael Almskov Jun 19, 2019 3:15PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Blackrock now owns 5% of the shares in genmab
Martin Lynge
Martin Lynge Feb 25, 2019 9:08AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Interesting to see, if we go beyond 1120 this time...
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email